Schedule 13G
FEED Schedule 13G filing by Bank of America
Bank of America reported beneficial ownership of 234.2K shares, representing 21.5% of ENvue Medical, Inc. in this filing.
FiledFeb 6, 2026
Ownership dateJan 30, 2026
Reported shares234.2K
Reported ownership21.5%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
0
Shared voting power
234.2K
Sole dispositive power
0
Shared dispositive power
234.2K
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$2.92as of Feb 6, 2026
Latest tracked price$0.38as of Aug 7, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Bank of America
- CIK
- CIK0000070858
- Accession
- 0000070858-26-000039
- Form
- Schedule 13G
Read the filing in context